Search for: "Schering-Plough Corporation" Results 41 - 60 of 100
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Dec 2009, 9:45 am by Karen E. Keller
(patent infringement) 11/25: Schering-Plough Healthcare Products, Inc. v. [read post]
4 Sep 2008, 1:06 am
  Negative press has made Schering-Plough's stock "radioactive. [read post]
27 Jan 2009, 7:02 am
In addition, Schering-Plough has said it will survey investors on its pay practices. [read post]
25 Mar 2011, 4:29 pm by Eric Schweibenz
., Inc. of Whitehouse Station, New Jersey Schering Plough Corporation of Kenilworth, New Jersey Organon USA, Inc. of Durham, North Carolina N.V. [read post]
9 Jul 2008, 11:12 am
Paul Smith, Partner at Eversheds who co-chaired the conference with Tom Sabatino, General Counsel of Schering-Plough, says, "Over the last year we've had anecdotal evidence from clients that their global demands are mushrooming, whether in Abu Dhabi or Bucharest or China. [read post]
16 Jul 2012, 1:18 pm by Jeffrey May
The appellate court decided that wholesalers and retailers who purchased a brand-name sustained-release potassium chloride supplement (K-Dur) used to treat high blood pressure could proceed with an antitrust challenge  to patent infringement litigation settlement agreements between Schering-Plough Corporation — the manufacturer of K-Dur — and generic drug companies. [read post]
16 Jul 2012, 1:18 pm by Jeffrey May
The appellate court decided that wholesalers and retailers who purchased a brand-name sustained-release potassium chloride supplement (K-Dur) used to treat high blood pressure could proceed with an antitrust challenge  to patent infringement litigation settlement agreements between Schering-Plough Corporation — the manufacturer of K-Dur — and generic drug companies. [read post]
24 Aug 2012, 7:46 pm by Lyle Denniston
.” This dispute involves the marketing of a supplement for treating side effects that result from the use of high-blood-pressure medicines;  Schering-Plough Corporation — now owned by Merck – won a patent in 1989 for its product under the brand name “K-Dur.”   The patent is not for the underlying substance — potassium chloride — but rather for an invention that coats small particles of that… [read post]
14 Apr 2010, 1:05 pm by Joe Consumer
Clark's money is nothing compared to the compensation packages of execs at Schering-Plough, which Merck bought last year, who apparently, "walked away with massive pay packages, thanks to 'golden handshake' deals that were part of their pay agreements with Schering. [read post]
14 Apr 2010, 1:05 pm by Joe Consumer
Clark's money is nothing compared to the compensation packages of execs at Schering-Plough, which Merck bought last year, who apparently, "walked away with massive pay packages, thanks to 'golden handshake' deals that were part of their pay agreements with Schering. [read post]
5 Aug 2009, 12:50 pm
Corporate America, however, can not have it both ways. [read post]
20 Apr 2010, 5:07 pm by Dr. Shezad Malik
., and Schering-Plough Corporation, not only knew about the potential side effects associated with NUVARING®, but concealed those risks from the public, including the FDA during the approval process. [read post]
11 Sep 2009, 3:00 pm
Prior to Secretary Wells' appointment, she was President of the Schering-Plough Foundation, the philanthropic arm of the Schering Plough Corporation and the Vice-President of Public Affairs at Schering-Plough Corporation. [read post]
31 Dec 2009, 7:19 am
’s proposed $68 billion acquisition of Wyeth, and Schering-Plough Corporation was permitted to proceed with its proposed $41.1 billion acquisition of Merck & Co. [read post]
20 Aug 2010, 12:56 pm by Stephen Albainy-Jenei
Significant Case Studies Give You The Chance To Learn About New Partnerships and New Agreements In The Industry * BMS and Allergan * Merck and Schering-Plough * Sanofi-Aventis and Intelliject * J&J and Takeda * Eli Lilly and Kowa Pharmaceuticals * Eli Lilly and Incyte Corporation The Perfect Pitch: Biotech Investment Challenge In this groundbreaking session, Biotech companies will have the chance to present your new research and new therapies (either in early stages or… [read post]
23 May 2011, 1:54 pm by FDABlog HPM
(“Merck”) (formerly Schering-Plough Corporation) restricted competition in violation of the Sherman Act by settling patent infringement lawsuits against potential generic K-DUR entrants. [read post]
9 Oct 2011, 4:35 pm by Lawrence B. Ebert
Schering-Plough and Wyeth added jobs - and subsequently were swallowed Merck and Pfizer, respectively. [read post]